Patient-Derived Tumor Models: A More Suitable Tool for Pre-Clinical Studies in Colorectal Cancer

Scientists highlight the advantages and limits of patient-derived models as innovative and valuable pre-clinical tools to study progression and metastasis of colorectal cancer, develop novel therapeutic strategies by creating a drug screening platform, and predict the efficacy of clinical response to therapy.